GlassScriptPhysician profile
Anthony B Lewis
NPI 1396776522
$8,467.69
in general payments reported to CMS, 2019-2025
29 companies · $713 in 2025
The $713 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,917 · 2020: $568 · 2021: $877 · 2022: $840 · 2023: $1,329 · 2024: $2,225 · 2025: $713.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,186 · Travel and Lodging: $1,069 · Education: $12.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,185.82 |
| Travel and Lodging | $1,068.76 |
| Education | $12.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,423.69 | 2019-2025 | Aveir, Amplatzer Amulet |
| Boston Scientific Corporation | $1,387.83 | 2023-2024 | Watchman Flx, Varithena Administration Pack, Watchman |
| Medtronic Vascular, INC. | $1,234.88 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $592.42 | 2021-2025 | Verquvo, Belsomra, Januvia |
| Novartis Pharmaceuticals Corporation | $578.95 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $547.06 | 2019-2025 | Lokelma, Farxiga |
| Pfizer INC. | $433.56 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $431.35 | 2019-2023 | Xarelto |
| Medtronic, INC. | $418.66 | 2021-2023 | Closurefast, Mycarelink, Linq II |
| Boehringer Ingelheim Pharmaceuticals, INC. | $263.88 | 2021-2023 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $217.60 | 2023-2025 | Lifevest |
| Cvrx, INC. | $149.29 | 2023-2025 | Barostim Neo System |
| Becton, Dickinson and Company | $147.11 | 2024 | Venclose Maven Catheter |
| Bayer Healthcare Pharmaceuticals INC. | $118.27 | 2023-2025 | |
| Amgen INC. | $105.50 | 2024-2025 | Repatha |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $82.01 | 2019-2024 | Eliquis, Camzyos |
| Lexicon Pharmaceuticals, INC. | $62.99 | 2024 | |
| Amarin Pharma, INC. | $41.02 | 2019 | |
| Kestra Medical Technology Services, INC. | $39.67 | 2024 | Assure Wcd |
| Kiniksa Pharmaceuticals, LTD. | $32.15 | 2022 | |
| Novo Nordisk INC | $23.27 | 2024 | Ozempic, Rybelsus |
| Bard Peripheral Vascular, INC. | $22.05 | 2022 | |
| Elutia, INC. | $21.65 | 2020 | |
| Sanofi-Aventis U.S. LLC | $19.87 | 2019 | |
| Vital Connect, INC | $16.66 | 2025 | Vitalpatch Rtm |
| Dexcom, INC. | $16.38 | 2023 | Dexcom G6 Transmitter |
| Biocompatibles, INC. | $16.08 | 2019 | |
| Esperion Therapeutics, INC. | $13.84 | 2020 | |
| Bardy Diagnostics, INC. | $10.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Lewis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.